Edition:
India

Profile: Caplin Point Laboratories Ltd (CAPL.BO)

CAPL.BO on Bombay Stock Exchange

694.90INR
18 Oct 2017
Change (% chg)

Rs-0.45 (-0.06%)
Prev Close
Rs695.35
Open
Rs696.00
Day's High
Rs707.65
Day's Low
Rs691.00
Volume
4,428
Avg. Vol
19,275
52-wk High
Rs783.90
52-wk Low
Rs285.00

Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers. The Company offers a range of products, including Tablets, Liquid Orals, Capsule, Softgel Capsules, Suppositories and Ovules, Powder for Injection, Dry syrup, Topicals, Liquid Injections, Inhalers, intravenous (IV) Infusion, Lyophilized Products, Branded Products, Dermo Cosmetics and Other Products. It also manufactures a range of ointments, creams, gels and lotions. The Company has presence in Latin American nations of Guatemala, Honduras, Nicaragua, El Salvador, Ecuador, Honduras, Venezuela and Dominican Republic. The Company's manufacturing facilities are located in Suthukeny village, Puducherry; Gummidipoondi Taluk, Tamil Nadu, and Baddi, Himachal Pradesh. Its research and development units are located in Gummidipoondi Taluk, Tamil Nadu.

Company Address

Caplin Point Laboratories Ltd

NARBAVI
No. 3, Lakshmanan Street, T. Nag
CHENNAI     600017
P: +9144.28156653
F: +9144.28154952

Company Web Links